Trial · NCT03169881
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Bayley III Composite Cognitive Score | 22-26 months corrected age (a median of 25 months corrected age, which corresponds to a median of 29 months calendar age in the analysis population), unless the subject died earlier | The analysis population includes all randomized infants with available data up to the two-year followup. | score on a scale | MEAN |
| SECONDARY | Number of Transfusions Per Infant | Birth, up to the earliest of: death, hospital discharge, or 35 completed weeks gestational age (a median of 9 weeks) | The analysis population includes all randomized infants with available data during the initial hospitalization. | Transfusions | MEAN |
| SECONDARY | Total Volume of Transfusions Per Infant | Birth, up to the earliest of: death, hospital discharge, or 35 completed weeks gestational age (a median of 9 weeks) | The analysis population includes all randomized infants that were ever transfused. | mL | MEAN |
| SECONDARY | Number of Donor Exposures Per Infant | Birth, up to the earliest of: death, hospital discharge, or 35 completed weeks gestational age (a median of 9 weeks) | The analysis population includes all randomized infants with available data during the initial hospitalization. | Donors | MEAN |
| SECONDARY | Hematocrit | at 2 and at 7 weeks in the study | The analysis population includes all randomized infants with available data during the initial hospitalization. | Percent of blood volume made up of RBCs | LEAST_SQUARES_MEAN |
| SECONDARY | Red Cell Mass | at 2 and at 7 weeks in the study | The analysis population includes all randomized infants with available data during the initial hospitalization. | mL | LEAST_SQUARES_MEAN |
| SECONDARY | Necrotizing Enterocolitis, Bells Stage >=2 With Surgery | Birth to initial hospital discharge or to death if it occurs earlier (a median of 94 days) | The analysis population includes all randomized infants with available data during the initial hospitalization. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Bronchopulmonary Dysplasia Grades 2 or 3 | At 36 weeks postmenstrual age | The analysis population includes all randomized infants with available data during the initial hospitalization. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Retinopathy of Prematurity Stage >=3 or Treatment for That Condition Received | Birth to initial hospital discharge or to death if it occurs earlier (a median of 94 days) | The analysis population includes all randomized infants with available data during the initial hospitalization. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Intraventricular Hemorrhage Grade I+ | Birth to initial hospital discharge or to death if it occurs earlier (a median of 94 days) | The analysis population includes all randomized infants with available data during the initial hospitalization. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Length of Hospital Stay | At initial hospital discharge or at death if it occurs earlier (a median of 94 days), assessed up to one year of life. | The analysis population includes all randomized infants with available data during the initial hospitalization. | Days | MEAN |
| SECONDARY | Death | Birth, through the 22-26 months corrected age follow-up window, which corresponds to a median of 29 months calendar age in the analysis population | The analysis population includes all randomized infants with available data up to the two-year followup. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Neurodevelopmental Impairment | At 22-26 months corrected age (a median of 25 months corrected age) | The analysis population includes all randomized infants with available data at the two-year followup. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Any Cerebral Palsy | At 22-26 months corrected age (a median of 25 months corrected age) | The analysis population includes all randomized infants with available data at the two-year followup. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03169881/outcomes